Clinical Trial

A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France

Name: A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France — clinical trial record (NCT07343089)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BorDiMab

Recruiting

View on ClinicalTrials.gov →

Summary

Clinical, biological, radiological, and pharmacological description of cases of disseminated borreliosis (Borrelia burgdorferi sl. and Borrelia miyamotoi) occurring in patients who received drug treatment based on anti-CD20 monoclonal antibodies.

Trial Details

NCT Number	NCT07343089
Lead Sponsor	University Hospital, Strasbourg, France
Conditions	Borrelia Infections
Enrollment	100 participants
Start Date	2025-08-29
Primary Completion	2026-08 (estimated)
Study Completion	2026-08-29 (estimated)
Updated on ClinicalTrials.gov	2026-01-15